Exciting news from Bluebirdbio studies

8th September 2017

We are thrilled to share news that bluebird bio™ have announced two exciting updates for the Starbeam and ALD-101 studies. ALD Life are honoured to have bluebird bio™ as trusted allies in the fight against ALD and AMN and we hope you’ll be as excited as we are at the continued success of their gene therapy trial.


To read this report please click here.


2 days ago

ALD Life

European Reference Networks (ERNs) connect patients, clinicians and researchers across Europe, to provide rare disease patients with access to diagnosis and transformative care. ��Support the #ProtectERNS campaign by adding your signature:

Check out Genetic Alliance’s social media toolkit to help spread the word:

View on Facebook